EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • December 18th, 2013 • Retrophin, Inc. • Pharmaceutical preparations • New York
This Exclusive License Agreement (this “Agreement”) is made effective the 12th day of December, 2013 (the “Effective Date”), by and between Stuart Weg, MD, an individual (“Licensor”), and Retrophin, Inc. (“Licensee”), a corporation organized and existing under the laws of Delaware. Licensor and Licensee are each referred to herein individually as a “Party” and together as the “Parties”.
LICENSE AGREEMENT between NOVARTIS PHARMA AG NOVARTIS AG and RETROPHIN, INC.License Agreement • December 18th, 2013 • Retrophin, Inc. • Pharmaceutical preparations • New York
EMPLOYMENT AGREEMENTEmployment Agreement • December 18th, 2013 • Retrophin, Inc. • Pharmaceutical preparations • New York
This Employment Agreement dated as of December 16, 2013 (the “Agreement”), is made by and between Retrophin, Inc. (together with any successor thereto, the “Company”), a Delaware corporation, and Martin Shkreli (the “Executive”) (collectively referred to as the “Parties”).
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • December 18th, 2013 • Retrophin, Inc. • Pharmaceutical preparations
This Agreement is made by and between Retrophin, Inc. ("Company") with offices at 777 Third Avenue, 22nd Floor, New York, NY 10017, and The Regents of the University of California, on behalf of its San Diego campus, having its office at 9500 Gilman Drive, La Jolla, CA 92093-0934, ("University").
